Amitriptyline 150mg Tablet PCD Franchise in Ahmedabad

Neuropathic Pain Management Tablet Supplier in Bangalore

Amitriptyline 150mg Tablet Distributor in Hyderabad

Antidepressant & Pain Relief Tablet Franchise Opportunity in Jaipur

Amitriptyline Segment Stockist in Mumbai
Neuropathic Pain & Mental Health Tablet Export and Manufacturing in Chandigarh

Home/Products /amitriptyline-150mg-tablet

Trypamin 150 Tablet

Composition : Amitriptyline (150mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Trypamin 150 Tablet contains Amitriptyline 150mg, a tricyclic antidepressant widely prescribed for neuropathic pain, depressive disorders, anxiety, and chronic tension-type headaches. It works by enhancing serotonin and norepinephrine levels in the brain to improve mood, sleep, and pain perception.

This formulation helps relieve persistent nerve pain conditions such as diabetic neuropathy, sciatica, post-herpetic neuralgia, and fibromyalgia. It also reduces migraine frequency and improves sleep quality in patients with chronic pain syndromes.

For distributors and franchise partners, Trypamin 150 is a strong-performing neurology and pain management segment product, recommended regularly by psychiatrists, neurologists, and pain specialists, ensuring consistent demand and repeat prescriptions.

Adding Trypamin 150 Tablet to your portfolio strengthens your presence in the neuropathic pain, mental health, and chronic pain category, helping businesses scale faster with a proven, high-prescription medicine.

Read More

About the Product

Trypamin 150 Tablet contains Amitriptyline 150mg, a tricyclic antidepressant widely prescribed for neuropathic pain, depressive disorders, anxiety, and chronic tension-type headaches. It works by enhancing serotonin and norepinephrine levels in the brain to improve mood, sleep, and pain perception.

This formulation helps relieve persistent nerve pain conditions such as diabetic neuropathy, sciatica, post-herpetic neuralgia, and fibromyalgia. It also reduces migraine frequency and improves sleep quality in patients with chronic pain syndromes.

For distributors and franchise partners, Trypamin 150 is a strong-performing neurology and pain management segment product, recommended regularly by psychiatrists, neurologists, and pain specialists, ensuring consistent demand and repeat prescriptions.

Adding Trypamin 150 Tablet to your portfolio strengthens your presence in the neuropathic pain, mental health, and chronic pain category, helping businesses scale faster with a proven, high-prescription medicine.

Possible side effects include drowsiness, dry mouth, constipation, dizziness, blurred vision, increased appetite, or weight gain. Rare but serious effects include arrhythmias, severe allergic reactions, confusion, or suicidal thoughts, especially in early treatment stages.

Trypamin 150 Tablet is indicated for major depressive disorder, anxiety disorders, chronic neuropathic pain, fibromyalgia, migraine prophylaxis, and certain sleep-related disorders. It helps relieve persistent low mood, anxiety, and nerve-related pain.

Use strictly under medical supervision, as this is a high-dose formulation. Avoid alcohol and activities requiring alertness. Not recommended in patients with recent heart attack, severe liver or kidney impairment, glaucoma, or known hypersensitivity to tricyclic antidepressants. Do not stop the medicine abruptly.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation